Calcineurin Inhibitor Market to reach US$ 20.64 Billion by 2030, Comprehensive Analysis at a CAGR of 10.8 %, Says Coherent Market Insights |
Calcineurin inhibitors (CNIs) are a class of immunosuppressive drugs widely used in transplantation medicine and autoimmune diseases. These medications